Invention Grant
US07939517B2 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses
失效
1,4,6-雄烯三烯-3,17-二酮（“ATD”）用于治疗用途
- Patent Title: 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses
- Patent Title (中): 1,4,6-雄烯三烯-3,17-二酮（“ATD”）用于治疗用途
-
Application No.: US11187043Application Date: 2005-07-22
-
Publication No.: US07939517B2Publication Date: 2011-05-10
- Inventor: Bruce W. Kneller
- Applicant: Bruce W. Kneller
- Agency: Morse, Barnes-Brown & Pendleton, P.C.
- Agent Lisa M. Treannie, Esq.
- Main IPC: A61K31/56
- IPC: A61K31/56 ; A61K31/5685
Abstract:
A composition having at least one modified or derivative of 1,4,6-androstatriene-3,17-dione (“ATD”) will improve the health of mammalian subjects. The improvement of health is achieved with the administration of an effective amount of at least one modified or derivative of 1,4,6-androstatriene-3,17-dione. Particularly, health is improved for a subject suffering with a gynecomastia and/or estrogen-dependent cancer. Also, subjects recovering from steroid misuse/abuse will benefit from treatment in accordance with the present invention.
Public/Granted literature
- US20060154909A1 1,4,6-androstatriene-3,17-dione ("ATD") for therapeutic uses Public/Granted day:2006-07-13
Information query
